Callan Family Office’s Centene CNC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.16M Buy
18,057
+1,834
+11% +$98K 0.02% 555
2026
Q1
$531K Sell
16,223
-1,185
-7% -$48.6K 0.01% 747
2025
Q4
$716K Buy
+17,408
New +$652K 0.02% 653
2025
Q3
– Sell
-21,795
Closed -$1.18M – 868
2025
Q2
$1.18M Buy
21,795
+13,529
+164% +$793K 0.04% 362
2025
Q1
$502K Sell
8,266
-9,410
-53% -$569K 0.04% 319
2024
Q4
$1.07M Buy
+17,676
New +$1.1M 0.07% 236

Other funds holding CNC

Callan Family Office's CNC Position: Q2 2026 in Review

Callan Family Office increased its Centene (CNC) stake by 11% in Q2 2026, buying an estimated $98K and bringing the position to 18,057 shares worth $1.16M. The position accounts for 0.02% of the portfolio, ranked #555.

Callan Family Office first reported a position in CNC in Q4 2024 and has held it in 6 quarters since. The position peaked at $1.18M in Q2 2025. 1,006 funds tracked by Wall St. Rank hold CNC as of Q2 2026.

  • Callan Family Office held 18,057 shares of Centene worth $1.16M as of Q2 2026.
  • Callan Family Office bought 1,834 Centene shares in Q2 2026, an estimated $98K.
  • Centene made up 0.02% of Callan Family Office's portfolio in Q2 2026, its #555 holding.
  • Callan Family Office first reported a position in Centene in Q4 2024 and has held it in 6 quarters since.
  • Callan Family Office's Centene position peaked at $1.18M in Q2 2025.
  • 1,006 funds tracked by Wall St. Rank held Centene as of Q2 2026.

Based on Callan Family Office's 13F filing for Q2 2026, filed 11 Aug 2026.